Treatment with a low-dose cocktail of fenofibrate, niacin, and atorvastatin successfully normalized the lipid profile and resolved milky blood in an infant with familial chylomicronemia syndrome.
Case Report (n=1)
Does a cocktail therapy of low-dose fenofibrate, niacin, and atorvastatin improve lipid profiles safely in an infant with familial chylomicronemia syndrome?
A cocktail therapy of low-dose fenofibrate, niacin, and atorvastatin successfully managed severe hypertriglyceridemia in an infant with familial chylomicronemia syndrome without causing further hepatic injury.
Familial chylomicronemia syndrome is a group of very rare genetic disorders. It is inherited as autosomal recessive disorder. Its estimated incidence is 1 in 1000000 populations, characterized by deficient activity of an enzyme lipoprotein lipase (LPL) or apo-protein C-II, resulting into severe fasting hypertriglyceridemia and massive accumulations of chylomicrons in plasma. LPL deficiency typically presents in childhood with failure to thrive, colicky abdominal pain, eruptive xanthomas, lipemiaretinalis, pancreatitis and hepatomegaly. We are reporting a rare case of familial chylomicronemia in a 20 days old child who was presented with pneumonia, his plasma incidentally found like milk during routine collection of his blood sample. As the child was only 20 days old with very high triglyceride level, so breast feeding continued and cocktail therapy with low dose Tablet Fenofibrate, Tablet Niacin, Tablet Atovastatin started after referral to paediatric cardiologist at 3 months of age. Journal of Armed Forces Medical College Bangladesh Vol.15 (1) 2019: 107-109
Begum et al. (Thu,) conducted a case report in Familial chylomicronemia syndrome (n=1). Cocktail therapy (Fenofibrate, Niacin, Atorvastatin) was evaluated on Normalization of lipid profile and resolution of milky blood. Treatment with a low-dose cocktail of fenofibrate, niacin, and atorvastatin successfully normalized the lipid profile and resolved milky blood in an infant with familial chylomicronemia syndrome.